Sleep and birthweight predict visceral adiposity in overweight/obese children

N Sokolovic1, R Kuriyan, A V Kurpad

  • 1Harvard College, Cambridge, MA, USA.

Pediatric Obesity
|March 21, 2013
PubMed

Insights

Higher birthweight and longer sleep duration in childhood may prevent visceral fat accumulation. These factors are crucial for managing obesity and preventing related health issues in children.

Area of Science:

  • Pediatric Endocrinology
  • Obesity Research
  • Public Health

Background:

  • Visceral adiposity is linked to adverse long-term health outcomes.
  • Preventing visceral fat deposition is crucial for overall well-being.
  • Understanding factors influencing fat distribution is essential.

Purpose of the Study:

  • To determine factors associated with varied fat distribution in overweight and obese children.
  • To investigate the relationship between demographic, dietary, and lifestyle factors and visceral adipose tissue.

Main Methods:

  • Study included overweight/obese South-Indian children aged 3-16 years.
  • Visceral obesity diagnosed using waist-to-height ratio (WHtR) ≥ 0.5.
  • Logistic regression analysis identified predictors of visceral adiposity.

Main Results:

  • Higher birthweight (OR 1.30) and increased sleep duration (OR 1.26) were significant predictors of a healthy WHtR.
  • Statistical analyses identified key exposure variables differentiating WHtR categories.
  • Logistic regression model effectively predicted visceral adiposity.

Conclusions:

  • Early life factors, including birthweight, influence childhood obesity.
  • Inadequate sleep may contribute to visceral fat storage in overweight/obese children.
  • Addressing birthweight and sleep duration could be key strategies for preventing childhood visceral obesity.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Hypodermis01:02

Hypodermis

The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...